Comparison of α-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase

[1]  A. Belló-Klein,et al.  Total antioxidant capacity is impaired in different structures from aged rat brain , 2005, International Journal of Developmental Neuroscience.

[2]  K. Yoo,et al.  Copper chaperone for Cu,Zn-SOD supplement potentiates the Cu,Zn-SOD function of neuroprotective effects against ischemic neuronal damage in the gerbil hippocampus. , 2005, Free radical biology & medicine.

[3]  S. Kim,et al.  In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. , 2004, Free radical biology & medicine.

[4]  M. Morris,et al.  Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. , 2004, Biochemistry.

[5]  M. Kim,et al.  Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation , 2003, Neuroscience Letters.

[6]  D. Latchman,et al.  Modulation of cell death by α-synuclein is stimulus-dependent in mammalian cells , 2003, Neuroscience Letters.

[7]  A. Burny,et al.  Targeting Tat and IFNα as a Therapeutic AIDS Vaccine , 2002 .

[8]  J. Trojanowski,et al.  The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. , 2002, Free radical biology & medicine.

[9]  J. Trojanowski,et al.  Synucleinopathies: a pathological and molecular review , 2001, Clinical Neuroscience Research.

[10]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[11]  J. Trojanowski,et al.  Differential Expression and Distribution of α-, β-, and γ-Synuclein in the Developing Human Substantia Nigra , 2001, Experimental Neurology.

[12]  H. Braak,et al.  α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei , 2001, Acta Neuropathologica.

[13]  T. Kinoshita,et al.  Age‐related changes of cornu ammonis 1 pyramidal neurons in gerbil transient ischemia , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[14]  K. Kosaka,et al.  Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer’s disease , 2000, Journal of the Neurological Sciences.

[15]  E. Masliah,et al.  Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease* , 1999, The Journal of Biological Chemistry.

[16]  J. Mikkelsen,et al.  Developmental expression of α-synuclein in rat hippocampus and cerebral cortex , 1999, Neuroscience.

[17]  H. Braak,et al.  Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunocytochemistry , 1999, Neuroscience Letters.

[18]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[19]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[20]  A. Takahashi,et al.  Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus , 1998, Brain Research.

[21]  Hitoshi Takahashi,et al.  NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.

[22]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[23]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[24]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Nakajo,et al.  Cloning and Characterization of the cDNA Encoding a Novel Brain‐Specific 14‐kDa Protein , 1992, Journal of neurochemistry.

[26]  R. Scheller,et al.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane. , 1991, Brain research. Molecular brain research.

[27]  R. Scheller,et al.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  Takaaki Kirino,et al.  Delayed neuronal death in the gerbil hippocampus following ischemia , 1982, Brain Research.

[29]  Fred Plum,et al.  Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.

[30]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.